Murat Bakir
Overview
Explore the profile of Murat Bakir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karagoz B, Bakir M, Kececi T
Cureus
. 2022 Apr;
14(2):e22583.
PMID: 35371738
Purpose In this study, it was aimed to determine the quality and accuracy of the videos on YouTube about lateral epicondylitis. Methods The first 100 videos were included in the...
2.
Koc K, Cerig S, Ucar S, Colak S, Bakir M, Erol H, et al.
Drug Chem Toxicol
. 2018 Nov;
43(5):441-453.
PMID: 30426792
Ethnopharmacological studies demonstrated that thymol (Thym) and oleuropein (Ole) have therapeutic potential for gastric ulcers. The molecular mechanism underlying the gastroprotective effects of these compounds have not been elucidated yet...
3.
Bakir M, Geyikoglu F, Koc K, Cerig S
J Cancer Res Ther
. 2018 Jun;
14(3):671-678.
PMID: 29893338
Aims: Cisplatin (CIS) is an influential chemotherapeutic agent in the treatment of several types of malignant solid tumors, but its clinical use is related with ototoxicity. Oleuropein (OLE) is a...
4.
Geyikoglu F, Emir M, Colak S, Koc K, Turkez H, Bakir M, et al.
J Food Drug Anal
. 2017 Sep;
25(2):447-459.
PMID: 28911689
Cisplatin-based chemotherapy is responsible for a large number of renal failures, and it is still associated with high rates of mortality today. Oleuropein (OLE) presents a plethora of pharmacological beneficial...
5.
Geyikoglu F, Colak S, Turkez H, Bakir M, Koc K, Hosseinigouzdagani M, et al.
Indian J Hematol Blood Transfus
. 2017 Aug;
33(3):348-354.
PMID: 28824236
The prevalence of cancer, in the world is increasing steadily. Despite intense research efforts, no approved therapy is yet available. Cisplatin is a chemotherapeutic drug but induces acute tissue injury....
6.
Geyikoglu F, Isikgoz H, Onalan H, Colak S, Cerig S, Bakir M, et al.
J Asian Nat Prod Res
. 2017 Apr;
19(12):1214-1231.
PMID: 28429624
The current systemic treatments of the various solid tumors involve Cisplatin (CIS)-based chemotherapy. Due to its cytotoxicity, this approach is limited. Moreover, the safety of CIS is only discussed especially...
7.
Bakir M, Geyikoglu F, Colak S, Turkez H, Bakir T, Hosseinigouzdagani M
Cytotechnology
. 2015 Sep;
68(4):1131-46.
PMID: 26350272
Acute pancreatitis (AP) may cause significant persistent multi-organ dysfunction. Carvacrol (CAR) possesses a variety of biological and pharmacological properties. The aim of the present study was to analyze the hepatic...
8.
Kilic Y, Geyikoglu F, Colak S, Turkez H, Bakir M, Hsseinigouzdagani M
Cytotechnology
. 2015 Jun;
68(4):1243-56.
PMID: 26093481
Acute pancreatitis (AP) is considered as major problem around the world and the incidence of AP is increasing. Carvacrol (CAR), a monoterpenic phenol, has good antioxidant activity. This in vivo...
9.
Bakir T, Geyikoglu F, Colak S, Turkez H, Aslan A, Bakir M
Toxicol Ind Health
. 2013 Jul;
31(12):1304-17.
PMID: 23833245
Lichens are symbiotic organisms composed of a fungus joined to a photosynthesizing partner that can be either an alga or a cyanobacterium. They can be used as a novel bioresource...